Quest Diagnostics Incorporated (DGX) vs United Therapeutics Corporation (UTHR)
A side-by-side comparison of Quest Diagnostics Incorporated and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 3, 2026. Differences are shown without an overall score or investment verdict.
DGX
Quest Diagnostics Incorporated
$233.24HealthcareDelayed quote: Oct 2, 2026, 3:59 PM EDT
UTHR
United Therapeutics Corporation
$541.70HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — DGX vs UTHR
growth of $100 · dividends reinvested · last 10yDGX +237.5% (+12.9%/yr)UTHR +346.0% (+16.1%/yr)UTHR compounded faster over this window
DGX UTHR
DGX vs UTHR: by the numbers
- •DGX is the larger company ($25.74B vs $22.99B market cap).
- •UTHR trades at the lower trailing earnings multiple (19.41 vs 24.76 P/E), one valuation lens rather than an overall verdict.
- •UTHR converts more revenue to profit (41.56% vs 9.19% net margin).
- •UTHR grew revenue faster over the past five years (14.68% vs 0.89% CAGR).
- •DGX pays a dividend (1.08% yield), while UTHR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | DGX | UTHR |
|---|---|---|
| P/E ratio | 24.76 | 19.41 |
| Forward P/E | 20.84 | 20.74 |
| PEG ratio | N/A | 1.01 |
| P/S ratio | 2.23 | 7.29 |
| P/B ratio | 3.43 | 3.59 |
| EV / EBITDA | 15.77 | 14.17 |
| FCF yield | 4.74% | 4.75% |
Profitability
| Metric | DGX | UTHR |
|---|---|---|
| Gross margin | 33.15% | 86.14% |
| Operating margin | 14.14% | 44.49% |
| Net margin | 9.19% | 41.56% |
| ROE | 14.13% | 20.48% |
| ROIC | 8.25% | 17.69% |
Dividends
| Metric | DGX | UTHR |
|---|---|---|
| Dividend yield | 1.08% | N/A |
| Payout ratio | 26.75% | N/A |
Growth (annualized)
| Metric | DGX | UTHR |
|---|---|---|
| Revenue CAGR (5Y) | 0.89% | 14.68% |
| EPS CAGR (5Y) | -3.65% | 20.93% |
| FCF CAGR (5Y) | -10.89% | 14.31% |
| Total return CAGR (5Y) | 12.51% | 23.84% |
Frequently asked
- Which has the lower trailing P/E, DGX or UTHR?
- UTHR has the lower trailing P/E: DGX trades at 24.76 and UTHR at 19.41. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, DGX or UTHR?
- Over the past five years, UTHR grew revenue faster — DGX at a 0.89% CAGR versus UTHR at 14.68%.
- Does DGX or UTHR pay a bigger dividend?
- DGX pays a dividend (1.08% yield), while UTHR has no payments in the available dividend history.
- Is DGX or UTHR more profitable?
- UTHR runs the higher net margin — DGX at 9.19% versus UTHR at 41.56%.
- How have DGX and UTHR total returns compared?
- Over the past 10 years, DGX delivered 12.87% and UTHR delivered 16.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Quest Diagnostics P/E ratioUnited Therapeutics P/E ratioQuest Diagnostics dividend yieldQuest Diagnostics ROEUnited Therapeutics ROEQuest Diagnostics operating marginUnited Therapeutics operating marginQuest Diagnostics revenue growthUnited Therapeutics revenue growthQuest Diagnostics free cash flowUnited Therapeutics free cash flow
Quest Diagnostics & United Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 3, 2026.